dc.contributor | Departament de Salut |
dc.contributor.author | Programa d'Harmonització Farmacoterapèutica |
dc.date.accessioned | 2019-05-20T10:51:51Z |
dc.date.available | 2019-05-20T10:51:51Z |
dc.date.issued | 2019-01-25 |
dc.identifier.citation | Programa d'Harmonització Farmacoterapèutica. Beclometasona/ formoterol/ bromur de glicopirroni per al tractament de manteniment de la malaltia pulmonar obstructiva crònica. Barcelona: Servei Català de la Salut; 2019. |
dc.identifier.uri | https://hdl.handle.net/11351/4074 |
dc.description | Obstructive pulmonary disease; Glycopyrronium bromide; Adult patients |
dc.description.abstract | Beclometasone / formoterol / glycopyrromine bromide (BECLO / FOR / GLIC) is a combination of fixed doses (CDF) of an inhaled corticosteroid (CI), a long beta-2-adrenergic agonist duration (LABA) and a long-term muscarinic antagonist (LAMA). It is indicated in the maintenance treatment of patients with moderate to severe chronic obstructive pulmonary disease (COPD) that are not adequately controlled with the combination of a CI and a LABA or with the combination of a LABA and a LAMA. However, their funding is restricted to patients already treated with triple therapy that respond
Suitable for drugs on separate devices. |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.relation.ispartof | Programa d'Harmonització Farmacoterapèutica, Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Medicaments - Assaigs clínics |
dc.subject | Formoterol - Ús terapèutic |
dc.subject | Pulmons - Malalties obstructives |
dc.subject.mesh | Beclomethasone |
dc.subject.mesh | Lung Diseases, Obstructive |
dc.subject.mesh | Drug Evaluation |
dc.subject.mesh | /drug therapy |
dc.title | Beclometasona/ formoterol/ bromur de glicopirroni per al tractament de manteniment de la malaltia pulmonar obstructiva crònica |
dc.type | info:eu-repo/semantics/report |
dc.subject.decs | beclometasona |
dc.subject.decs | enfermedades pulmonares obstructivas |
dc.subject.decs | evaluación de medicamentos |
dc.subject.decs | /tratamiento farmacológico |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |